1-es típusú cukorbetegség: vizsgálatok itt: Egyesült Királyság
33 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
- Where
- Birmingham, London
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07457580 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Airdrie, Chippenham, Hull, Llandough, Rotherham
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisTaking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Birmingham, Cambridge, Cardiff, Glasgow, London, Oxford, Southampton
- Életkor
- 1 év to 35 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - 3. fázisTaking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Aberdeen, Birmingham, Bristol, Cambridge, Cardiff, Oxford, Southampton
- Életkor
- 1 év to 35 év
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - No phaseTaking peopleClosed Loop and Education for Hypoglycemia Awareness Restoration
- Where
- Leicester, Sheffield
- Életkor
- 18 év to 75 év
- People
- 324 worldwide
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT06325202 - 3. fázisTaking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Bath, Cambridge, Dundee, Glasgow, Guildford, Leeds, London, Reading, Sheffield
- Életkor
- 1 év to 25 év
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - 2. fázisTaking peopleSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Where
- Cambridge, Cardiff, Edinburgh, Liverpool, London, Nottingham, Oxford
- Életkor
- 5 év to 40 év
- People
- 159 worldwide
- Run by
- SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Edinburgh, London
- Életkor
- 18 év to 99 év
- People
- 24 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - No phaseTaking peopleBenefits of Retained Insulin for Good Health
- Where
- Bath, Bristol, Exeter, Truro
- Életkor
- 18 év and over
- People
- 700
- Run by
- Royal Devon and Exeter NHS Foundation Trust
See details and how to joinNCT07828626 - 3. fázisTaking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Edinburgh, Headington, London, Newcastle upon Tyne
- Életkor
- 18 év to 65 év
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - 3. fázisTaking peopleAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Bristol, Coventry, Hull, Ipswich, Londonderry, Newquay, Rotherham, Swansea, Wallasey, Yeovil
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - No phaseNot yet taking people in Egyesült KirályságImplementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)
- Where
- London
- Életkor
- 18 év and over
- People
- 70
- Run by
- Imperial College Healthcare NHS Trust
See details and how to joinNCT07769138 - No phaseNot yet taking people in Egyesült KirályságDiathermy On Diabetes Glucose Monitoring Effectiveness
- Where
- Nottingham
- Életkor
- 4 év and over
- People
- 126
- Run by
- University of Nottingham
See details and how to joinNCT07583238 - No phaseTaking peopleRebalancing the Fat Content of the Heart and Muscles
- Where
- Aberdeen
- Életkor
- 20 év to 75 év
- People
- 60
- Run by
- University of Aberdeen
See details and how to joinNCT07065383 - No phaseNot yet taking people in Egyesült KirályságEvaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
- Where
- Cambridge, Leicester, Manchester
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Medtronic MiniMed, Inc.
See details and how to joinNCT07401901 - No phaseTaking peopleCapillary OGTT Study
- Where
- Cardiff, London, Nottingham, Oxford
- Életkor
- Up to 17 év
- People
- 135
- Run by
- University of Oxford
See details and how to joinNCT06815081 - 2. fázisTaking peopleSotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
- Where
- Aberdeen, Cambridge, Dundee, Edinburgh, Glasgow, Leicester, Liverpool, Llanelli, London, Manchester, Sheffield, Southampton, Sutton in Ashfield
- Életkor
- 18 év to 84 év
- People
- 320
- Run by
- University of Dundee
See details and how to joinNCT06435156 - No phaseTaking peopleCONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes
- Where
- Edinburgh, Glasgow, Ipswich, Leeds, Southampton
- Életkor
- 6 év and over
- People
- 225 worldwide
- Run by
- University of Manitoba
See details and how to joinNCT05754567 - No phaseTaking peopleFeasibility of a Tailored Online Self-compassion Intervention
- Where
- Bangor, London
- Életkor
- 18 év to 99 év
- People
- 50
- Run by
- Canterbury Christ Church University
See details and how to joinNCT07051005 - No phaseTaking peopleAvoidance of Insulin-induced Lipohypertophy in People With Diabetes Using Ultrasound Scanning Within Diabetes Clinics
- Where
- London
- Életkor
- 18 év and over
- People
- 50
- Run by
- Imperial College London
See details and how to joinNCT06782568 - No phaseTaking peopleExercising in Hot Conditions: How Does it Effect Blood Glucose in People With T1D
- Where
- Liverpool
- Életkor
- 18 év to 65 év
- People
- 38
- Run by
- Liverpool John Moores University
See details and how to joinNCT07341243 - No phaseTaking peopleThe Seafarers' Continuous Glucose Monitoring Systems Study
- Where
- Guildford
- Életkor
- 18 év and over
- People
- 50
- Run by
- University of Surrey
See details and how to joinNCT07251257 - No phaseTaking peopleEXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Where
- Exeter, London
- Életkor
- Up to 70 év
- People
- 300 worldwide
- Run by
- University of Exeter
See details and how to joinNCT03369821 - No phaseTaking peopleOptimising the Delivery of Diabetes Distress Informed Care for Its Prevention, Detection, and Management in Adults With Type 1 Diabetes: a Feasibility Study (D-stress Study)
- Where
- Bath, Leicester, London
- Életkor
- 18 év and over
- People
- 110
- Run by
- Guy's and St Thomas' NHS Foundation Trust
See details and how to joinNCT07193446 - 4. fázisTaking peopleAnti-viral Action Against Type 1 Diabetes Autoimmunity
- Where
- Birmingham, Cambridge, Newcastle
- Életkor
- 3 hónap to 4 hónap
- People
- 2252 worldwide
- Run by
- Technical University of Munich
See details and how to joinNCT06452654